Brandicourt Not Ready To Raise Medivation Bid Just Yet

Sanofi has reiterated its interest in the acquisition of Medivation and the French pharma's CEO has toughened up his language. Meanwhile, despite lots of speculation about other potential suitors, none has yet to come forward publicly.